Virtual Medicinal Product (VMP)
-
Trilostane 120mg capsules
Name Details
Current Name
Trilostane 120mg capsules
|
Start Date
21-03-2005
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
H02CA01
BNF |
Current BNF
06070300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06070300
|
Start Date
21-03-2005
|
End Date
22-05-2012
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42090811000001108 |
21-07-2023 |
|
326034000 |
22-03-2005 |
20-07-2023 |
VMP Ingredients
VMP ingredients table
Trilostane |
Based on Ingredient Substance |
|
120 mg |
|
Name
Trilostane
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
120.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Trilostane
-
VMP
(Current) Trilostane 120mg capsules
Virtual Medicinal Product Pack (VMPP) Information